Your search for proton pump inhibitor returned 111 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Mpr-drug-news remove
News remove

Your search for proton pump inhibitor returned 111 results

Sort Results:

Relevant Recent

P & G Launches Prilosec OTC Wildberry

Procter & Gamble announced the launch of Prilosec OTC (omeprazole delayed-release tablets 20mg) Wildberry, a flavor-coated 24-hour pill for the treatment of frequent heartburn.

Proton Pump Inhibitor Use May Up Death Risk

The authors found that compared to the use of H2RA therapy, patients initiated on PPI therapy had a 25% increased risk of death (hazard ratio [HR] 1.25, 95% CI: 1.23-1.28).

FDA Expands Dexilant Use for Younger GERD Patients

Takeda announced that the Food and Drug Administration (FDA) has approved Dexilant (dexlansoprazole) delayed-release capsules and Dexilant SoluTab delayed-release orally-disintegrating tablets for patients aged 12-17 years with gastroesophageal reflux disease (GERD).

NSAID + PPI May Slash Bladder Cancer Risk

Nonsteroidal anti-inflammatory drugs (NSAIDs) have shown promise in preventing certain types of cancers, but their use can also carry an increased risk of gastric ulcers and potentially life-threatening bleeds. However, a new study suggests that combining a proton pump inhibitor with an NSAID could reduce the risk of bladder cancer by as much as 75 percent.